lenalidomide,rituximab,venetoclax
abbvie,roche
['venetoclax', 'ritux']
valeria: venetoclax, len &amp; ritux r/r mcl
jerkeman et al
- 59 pts, med age 73, med prior 2
- orr (63%) similar to prior r2 study but pts higher risk
- p53 mut did worse
- haemtox &amp; rash most signif aes
- some mrd- studies stopped did not relapse
#ash22 
Associate Professor of Haematology and lymphoma specialist at Oxford Cancer and Haematology centre. Christian, husband and father.